David has spent his entire professional career investing in private and public technology companies. Initially, he joined the group which became Citicorp Venture Capital Limited (“CVC”) in New York. He established CVC's West Coast Office in 1973 which served as the focus of CVC's investing activities in the western United States for over 15 years. In 1978, he left to co-found Arscott, Norton & Associates (“ANA”), which formed three venture capital funds whose $75 million in capital funded 36 high-technology companies, including Iomega, Lam Research and Dallas Semiconductor (subsequently merged with Maxim Semiconductor - “MXIM” on the NASDAQ). In 1988, David formed what is now Compass Technology Group. Compass funded Radio Therapeutics, acquired by Boston Scientific; Oculex Pharmaceuticals, acquired by Allergan; and Tesla Motors, Inc. (“TSLA” on the NASDAQ), among others. David’s premise for Compass is that information garnered in the venture capital investment process has direct applicability in the selection of high-potential publicly-traded investments. The San Francisco Bay Area, where Compass is headquartered, is home to the richest and most diverse collection of emerging public and private technology companies in the world. He co-manages the firm’s investment portfolios. David earned a B.A. degree in History and Economics at the College of Wooster in Wooster, Ohio and an MBA in Finance and Accounting at the University of Michigan Graduate School of Business. David served as a director of Lam Research Corporation (“LRCX” on NASDAQ) for over 30 years, retiring from the board in 2011. He is currently a director of Toolwire, Percutaneous Systems, and Dragnet Solutions. He serves as a Director and Trustee of the IT History Society ( http://www.ithistory.org/ ).
Semiconductor manufacturing, hardware, software, health and automotive technology
Universities Mentored For
Stanford, UC Berkeley and University of Michigan